Kyodo Pharmaceutical: Supervisory Board's review opinion on the list of incentive recipients reserved for the company's 2023 restricted stock incentive plan (as of the grant date)

SZSI · Mar 5

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.